Repurposing the Antiviral Drug, Valganciclovir to Treat Cytomegalovirus-Induced Hearing Loss

Project: Research project

Project Details

Description

Repurposing the Antiviral Drug, Valganciclovir to Treat Cytomegalovirus-Induced Hearing Loss
StatusActive
Effective start/end date10/1/219/30/23

Funding

  • University of Utah

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.